AGRN and plasma cell myeloma: Several phenotypes benefited considerably from the inclusion of plasma proteomics data (Supplementary Fig. 3d and Supplementary Notes), including C90 (multiple myeloma and malignant plasma cell neoplasms), with AUC improving from 0.63 to 0.85.